Fedha

Hisa unazofuatilia
Kwa nini DEVA imepungua kwa 2.66%?
Fahamu zaidi
DEVA:IST
Deva Holding AS
TRY 78.80
-2.66%
(-2.15) Siku 1
14 Okt, 10:56:28 GMT +3  ·   TRY
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya DEVA...
Fungua
TRY 80.80
Juu
TRY 80.80
Chini
TRY 78.60
Mtaji wa soko
15.75B
Wastani wa kiasi cha mauzo
elfu 634.66
Kiasi cha mauzo ya hisa
elfu 107.42
Juu kwa wiki 52
TRY 109.30
Chini kwa wiki 52
TRY 57.50
EPS
-TRY 4.21
Hisa za wawekezaji
200.02M
Idadi ya wafanyakazi
elfu 3
Fungua
TRY 80.80
Juu
TRY 80.80
Chini
TRY 78.60
Mtaji wa soko
15.75B
Wastani wa kiasi cha mauzo
elfu 634.66
Kiasi cha mauzo ya hisa
elfu 107.42
Juu kwa wiki 52
TRY 109.30
Chini kwa wiki 52
TRY 57.50
EPS
-TRY 4.21
Hisa za wawekezaji
200.02M
Idadi ya wafanyakazi
elfu 3
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
RealClearMarkets
RealClearMarkets
·
dakika 6 zilizopita
The Bigger Meaning of Italian Prosperity on Wall St
Simply Wall Street
Simply Wall Street
·
dakika 11 zilizopita
3 Inflation Stocks Linked To AI Chips And Oil Prices
Wasifu
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements. A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas. As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
Kuhusu Deva Holding AS
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 3.06
Lilianzishwa22 Sep 1958
Makao makuu-
Sekta-
Ripoti za awaliThamani zote katika TRY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika TRY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
4.47B
5.49B
6.33B
6.00B
Gharama ya bidhaa zilizouzwa
3.02B
3.84B
4.10B
2.82B
Gharama ya mapato
3.02B
3.84B
4.10B
2.82B
Gharama za utafiti na maendeleo
264.29M
174.34M
361.82M
480.63M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.30B
1.58B
1.60B
1.68B
Gharama ya uendeshaji
1.55B
1.74B
1.93B
2.07B
Jumla ya gharama za uendeshaji
4.58B
5.58B
6.03B
4.89B
Mapato ya uendeshaji
-102.14M
-89.10M
293.59M
1.11B
Mapato mengine yasiyo ya uendeshaji
337.87M
185.09M
663.10M
-172.42M
EBT ikijumuisha vipengee visivyo vya kawaida
-137.34M
-340.89M
585.37M
527.53M
EBT bila kujumuisha vipengee visivyo vya kawaida
-137.34M
-362.51M
586.40M
527.53M
Gharama ya kodi ya mapato
-116.52M
1.00B
682.64M
-86.52M
Kiwango cha kodi kinachotumika
84.84%
-294.28%
116.62%
-16.40%
Gharama nyingine za uendeshaji
-9.80M
-11.48M
-34.86M
-88.91M
Mapato halisi
-20.81M
-1.34B
-97.27M
614.05M
Kiwango cha faida halisi
-0.47%
-24.48%
-1.54%
10.23%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
59.54M
23.47M
114.43M
157.88M
Gharama ya riba
-617.63M
-656.70M
-542.37M
-662.77M
Jumla ya gharama halisi za riba
-558.09M
-633.23M
-427.95M
-504.88M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
237.92M
622.26M
701.87M
1.42B
Faida au hasara kutokana na uuzaji wa vipengee
-15.06M
-15.93M
-32.28M
-12.59M
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google